Arcturus Therapeutics
ARCT
$26.55
Share price
1.45%
Change (1 day)
-5.45%
Change (1 year)
Revenue for Arcturus Therapeutics (ARCT)
Revenue in 2023 (TTM): $0.15 B
According to Arcturus Therapeutics 's latest financial reports the company's current revenue (TTM) is $0.15 B. In 2022 the company made a revenue of $0.20 B an increase over the years 2021 revenue that were of $12.35 M.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Arcturus Therapeutics from 2013 to 2023
Annual revenue
| Year | Revenue | Change |
|---|---|---|
| 2023 (TTM) | $0.15 B | -23.33% |
| 2022 | $0.20 B | 1564.82% |
| 2021 | $12.35 M | 29.56% |
| 2020 | $9.53 M | -54.12% |
| 2019 | $20.78 M | 31.97% |
| 2018 | $15.75 M | -21.45% |
| 2017 | $20.05 M | |
| 2016 | N/A | |
| 2015 | N/A | |
| 2014 | N/A | |
| 2013 | N/A |
Revenue for similar companies or competitors
| Company | Revenue | Revenue differencediff. | Country |
|---|---|---|---|
 Nymox Pharmaceutical NYMX | N/A | N/A | Bahamas |
 NRC Health
NRC | $0.14 B | -5.81% | 🇺🇸 USA |